PHARMA & BIO PHARMA

Redhill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy...

Redhill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK Mark L. Levitt, M.D., Ph.D., and Medical Director at Redhill, said: “We are quickly advancing the preparations for a...
Biopharma, COVID-19, Covid-19 drug development, Biopharma companies, Fibroblast Therapy, Global Biopharma Industry, Biopharmaceutical, Biopharma Update, coronavirus biopharma, coronavirus vaccine new.

Global Biopharma Industry Pulling Out All the Stops to Address Coronavirus

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the world’s leading biopharmaceutical companies, have mobilized on an unprecedented scale to respond to the COVID-19 pandemic. The biopharmaceutical industry commits to accelerating its...
Biopharma news, coronavirus, biopharma industry, volatile market, radiopharmaceutical, heat biologics, research development, develop vaccines, membrane technology

Biopharma industry profitability in line with other R&D-heavy sectors

Even outside of election seasons, the prices drugmakers charge for medicines and the revenues and profits they rake in attract public scrutiny, much of it negative. But a new study indicates that while the...
Company Releases COVID-19 Antigens

Company Releases COVID-19 Antigens

The Native Antigen Company has commercially introduced antigens that have been specifically derived from the Wuhan strain of novel coronavirus, now named Covid-19, it was announced in a Feb. 12, 2019 press release. The recombinant...
Vaccination of coronavirus, coronavirus in china, coronavirus in biopharma, development in gene therapy, cell-based gene therapy in Europe, Human Gene Therapy Products advancement, Current Experience for Nonclinical Development, biopharma for treatment of emerging diseases, pharma companies in coronavirus

Coronavirus Vaccine as Biopharmaceutical Product

As Chinese Coronavirus Spreads, Biopharma and Governments Rush to Develop Vaccines China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured. This has passed the...
Recent Trends in Pharmaceutical biotechnology, development in biopharma, Drug development in biopharma industry, demonstration of bioequivalence, DSC in pharmaceutical biotechnology, development in biopharmaceutical analysis, advance technologies in biopharma, protein expression biopharma

Tools for the BioPharma Industry

Pharmaceutical Biotechnology Pharmaceutical biotechnology is an increasingly important area of science and technology, and contributes to design and delivery of new therapeutic drugs, the development of diagnostic agents for medical tests, and the beginnings of gene...

Novel Protein for Parkinson’s Generates Attention

A recent research has indicated that a protein initially believed to affect a little proportion of Parkinson’s disease cases now looks caught up in a larger, if not whole, proportion of the patients. A...